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Sequencing of the blaKPC-positive strain Proteus mirabilis AOUC-001 was performed using both the MiSeq and PacBio RS II
platforms and yielded a single molecule of 4,272,433 bp, representing the complete chromosome. Genome analysis showed the
presence of several acquired resistance determinants, including two copies of blaKPC-2 carried on a fragment of a KPC-producing
plasmid previously described in Klebsiella pneumoniae.
Received 10 May 2016 Accepted 11 May 2016 Published 23 June 2016
Citation Di Pilato V, Chiarelli A, Boinett CJ, Riccobono E, Harris SR, D’Andrea MM, Thomson NR, Rossolini GM, Giani T. 2016. Complete genome sequence of the first KPC-type
carbapenemase-positive Proteus mirabilis strain from a bloodstream infection. Genome Announc 4(3):e00607-16. doi:10.1128/genomeA.00607-16.
Copyright © 2016 Di Pilato et al. This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license.
Address correspondence to Tommaso Giani, tommaso.giani@unisi.it.
Proteus mirabilis is one of the leading agents of urinary tractinfections and can cause a number of different health care-
associated infections, including mainly respiratory tract and skin
infections, but also bacteremia (1). Due to a decreased suscepti-
bility to imipenem and an intrinsic resistance to polymyxins and
tetracyclines (including tigecycline), the acquisition of -lactam
resistance traits by P. mirabilis might seriously limit treatment
options. KPC-type carbapenemases have become the most preva-
lent acquired carbapenemases in Klebsiella pneumoniae in several
areas worldwide (2) and have been sporadically detected also in
other Enterobacteriaceae and in Gram-negative nonfermenters
(3–6). The acquisition of blaKPC by P. mirabilis represents a rare
event, and only a few descriptions have been reported to date
(7–9). In this report, we announce the first complete genome se-
quence of a P. mirabilis strain carrying the blaKPC-2 gene.
P. mirabilis AOUC-001 was isolated in 2013 from the blood
culture from an inpatient admitted to the Santa Maria Annunziata
Hospital (Florence, Italy). A molecular test performed directly on
positive blood culture, using the FilmArray platform (Biofire Di-
agnostics, UT), detected the presence of the blaKPC gene.
Bacterial DNA was subjected to whole-genome sequencing us-
ing the MiSeq (Illumina, Inc., CA) and the PacBio RS II (Pacific
Biosciences, CA, USA) platforms, which generated 4,643,660 and
1,841,288 reads, respectively. Short and long raw reads were pro-
cessed with the PBcR hybrid assembly pipeline (10), producing 8
scaffolds (largest scaffold, 1.96 Mb; N50, 1.52 Mb; L50, 2; average
GC content, 39.42%). Genome finishing was achieved by man-
ual inspection of the draft assembly, exploiting PacBio long reads
for resolution of large repeats, and using short reads to close small
gaps (11). The final de novo assembly generated a single molecule
of 4,272,433 bp, with a raw coverage of 260, representing the
complete chromosome of AOUC-001.
A total of 3,853 coding sequences, 83 tRNAs, 22 rRNAs, and 1
type-IE clustered regularly interspaced short palindromic repeat
(CRISPR)-associated (Cas) system were identified by the NCBI
Prokaryotic Genome Annotation Pipeline (http://www.ncbi.nlm
.nih.gov/genome/annotation_prok).
Screening for known virulence determinants (12) revealed the
presence of genes associated with adhesion (mannose-resistant/
Proteus-like fimbria [MR/P], P. mirabilis fimbria [PMF], and
ambient-temperature fimbria [ATF] operons), motility (flgE,
fliFL, cheW, and flaD), iron chelation (hmurR2, znuC, and nrp
operon), and production of toxic compounds (pta, hpmA, and
zapA).
The antimicrobial resistome of AOUC-001, investigated
using ResFinder (13), included acquired determinants confer-
ring resistance to aminoglycosides (aadA1, aacA4, armA,
and aph(3=)-Ic), chloramphenicol (cat and catA1), trim-
ethoprim (dfrA1), and sulfonamides (sul1). Additionally, four
different -lactamase genes (blaCMY-16, blaTEM-1, blaOXA-9, and
blaKPC-2) were detected. Interestingly, the blaKPC-2 gene was
present in two copies.
Further analysis revealed that the two blaKPC-2 copies were em-
bedded in two distinct Tn4401a transposons (14), arranged in a
tail-to-tail configuration within the chromosome of AOUC-001.
The flanking sequences of these transposons resembled the overall
architecture of pKPN101-IT (accession no. JX283456), a KPC-
encoding plasmid taken from a K. pneumoniae clinical isolate de-
scribed in Italy in 2012 (15). Overall, this arrangement suggested a
possible integration of a pKPN101-IT-like plasmid within the
chromosome of AOUC-001, an event that might have been fa-
vored by the endemic presence of KPC-producing K. pneumoniae
strains sharing the same setting (16).
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Nucleotide sequence accession number. The complete ge-
nome of P. mirabilis AOUC-001 has been deposited at NCBI un-
der the GenBank accession no. CP015347.
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